Abstract
Summary
Market Overview:
The global sleep apnea devices market size reached US$ 7.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.2 Billion by 2028, exhibiting a growth rate (CAGR) of 6.8% during 2023-2028.
Sleep apnea, or sleep-disordered breathing (SDB), is an acute medical condition in which oxygen supply to the brain is obstructed during sleep. It is caused by blockages in the airway resulting in irregular breathing patterns and loud snoring, with the individual often gasping for breath. Sleep apnea diagnostic and therapeutic devices, such as Continuous Positive Airway Pressure (CPAP), Bilevel Positive Airway Pressure (BiPAP) and Variable Positive Airway Pressure (VPAP) machines, are used to evaluate the patient’s respiratory and other bodily functions during sleep. Apart from this, numerous oral devices, including the Mandibular Advancement Device (MAD) and tongue retaining device, are also utilized to treat mild to moderate cases of sleep apnea.
The increasing prevalence of obstructive sleep apnea disorder (OSA), central sleep apnea and complex sleep apnea syndrome, are among the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs), which is facilitating product adoption across both the developed and emerging nations. Furthermore, product innovations, including Out-of-Center (OOC) testing devices that examine sleep patterns, cardiovascular, oximetry and respiratory parameters for the diagnosis of OSA is also acting as another major growth-inducing factor. Other factors, including improving healthcare infrastructure and growing awareness regarding the prolonged effects of sleep apnea, along with the miniaturization and launch of affordable devices by various brands, are projected to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global sleep apnea devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type and end-user.
Breakup by Product Type:
Therapeutic Devices
Positive Airway Pressure (PAP) Devices
Oral Devices
Nasal Devices
Chin Straps
Others
Diagnostic Devices
Actigraphs
Polysomnography Devices
Sleep Screening Devices
Breakup by End-User:
Hospitals and Clinics
Sleep Laboratories
Homecare Settings
Others
Brealup by Region:
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Argentina
Colombia
Chile
Peru
Others
Middle East and Africa
Turkey
Saudi Arabia
Iran
United Arab Emirates
Others
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being BMC Medical Co., Braebon Medical Corporation, Cadwell Laboratories, CareFusion Corp., Curative Medical, Devilbiss Healthcare, Fisher & Paykel Healthcare, GE Healthcare, Invacare, Oventus Medical, Panthera Dental, ResMed, Somnomed Ltd., Vyaire Medical Inc., Whole You Inc., etc.
Key Questions Answered in This Report:
What was the size of the global sleep apnea devices market in 2022?
What is the expected growth rate of the global sleep apnea devices market during 2023-2028?
What has been the impact of COVID-19 on the global sleep apnea devices market?
What are the key factors driving the global sleep apnea devices market?
What is the breakup of the global sleep apnea devices market based on the product type?
What is the breakup of the global sleep apnea devices market based on the end-user?
What are the key regions in the global sleep apnea devices market?
Who are the key players/companies in the global sleep apnea devices market?
Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Sleep Apnea Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Therapeutic Devices
6.1.1 Market Trends
6.1.2 Market Breakup by Type
- 6.1.2.1 Positive Airway Pressure (PAP) Devices
- 6.1.2.1.1 Market Trends
- 6.1.2.1.2 Market Forecast
- 6.1.2.2 Oral Devices
- 6.1.2.2.1 Market Trends
- 6.1.2.2.2 Market Forecast
- 6.1.2.3 Nasal Devices
- 6.1.2.3.1 Market Trends
- 6.1.2.3.2 Market Forecast
- 6.1.2.4 Chin Straps
- 6.1.2.4.1 Market Trends
- 6.1.2.4.2 Market Forecast
- 6.1.2.5 Others
- 6.1.2.5.1 Market Trends
- 6.1.2.5.2 Market Forecast
- 6.1.2.1 Positive Airway Pressure (PAP) Devices
6.1.3 Market Forecast
6.2 Diagnostic Devices
6.2.1 Market Trends
6.2.2 Market Breakup by Type
- 6.2.2.1 Actigraphs
- 6.2.2.1.1 Market Trends
- 6.2.2.1.2 Market Forecast
- 6.2.2.2 Polysomnography Devices
- 6.2.2.2.1 Market Trends
- 6.2.2.2.2 Market Forecast
- 6.2.2.3 Sleep Screening Devices
- 6.2.2.3.1 Market Trends
- 6.2.2.3.2 Market Forecast
- 6.2.2.4 Others
- 6.2.2.4.1 Market Trends
- 6.2.2.4.2 Market Forecast
- 6.2.2.1 Actigraphs
6.2.3 Market Forecast
7 Market Breakup by End-User
7.1 Hospitals and Clinics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Sleep Laboratories
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Homecare Settings
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
8.2 Europe
8.2.1 Germany
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
8.2.2 France
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
8.2.3 United Kingdom
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
8.2.4 Italy
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
8.2.5 Spain
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
8.2.6 Russia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
8.3 Asia Pacific
8.3.1 China
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
8.3.2 Japan
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
8.3.3 India
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
8.3.4 South Korea
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
8.3.5 Australia
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
8.3.6 Indonesia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
8.4.3 Argentina
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
8.4.4 Colombia
- 8.4.4.1 Market Trends
- 8.4.4.2 Market Forecast
8.4.5 Chile
- 8.4.5.1 Market Trends
- 8.4.5.2 Market Forecast
8.4.6 Peru
- 8.4.6.1 Market Trends
- 8.4.6.2 Market Forecast
8.4.7 Others
- 8.4.7.1 Market Trends
- 8.4.7.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Turkey
- 8.5.1.1 Market Trends
- 8.5.1.2 Market Forecast
8.5.2 Saudi Arabia
- 8.5.2.1 Market Trends
- 8.5.2.2 Market Forecast
8.5.3 Iran
- 8.5.3.1 Market Trends
- 8.5.3.2 Market Forecast
8.5.4 United Arab Emirates
- 8.5.4.1 Market Trends
- 8.5.4.2 Market Forecast
8.5.5 Others
- 8.5.5.1 Market Trends
- 8.5.5.2 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Competitive Landscape
12.1 Market Structure
12.2 Key Players
12.3 Profiles of Key Players
12.3.1 BMC Medical Co
- 12.3.1.1 Company Overview
- 12.3.1.2 Product Portfolio
12.3.2 Braebon Medical Corporation
- 12.3.2.1 Company Overview
- 12.3.2.2 Product Portfolio
12.3.3 Cadwell Laboratories Inc
- 12.3.3.1 Company Overview
- 12.3.3.2 Product Portfolio
12.3.4 CareFusion Corp
- 12.3.4.1 Company Overview
- 12.3.4.2 Product Portfolio
12.3.5 Curative Medical Inc
- 12.3.5.1 Company Overview
- 12.3.5.2 Product Portfolio
12.3.6 Devilbiss Healthcare
- 12.3.6.1 Company Overview
- 12.3.6.2 Product Portfolio
12.3.7 Fisher & Paykel Healthcare
- 12.3.7.1 Company Overview
- 12.3.7.2 Product Portfolio
- 12.3.7.3 Financials
12.3.8 GE Healthcare
- 12.3.8.1 Company Overview
- 12.3.8.2 Product Portfolio
12.3.9 Invacare
- 12.3.9.1 Company Overview
- 12.3.9.2 Product Portfolio
- 12.3.9.3 Financials
- 12.3.9.4 SWOT Analysis
12.3.10 Oventus Medical
- 12.3.10.1 Company Overview
- 12.3.10.2 Product Portfolio
- 12.3.10.3 Financials
12.3.11 Panthera Dental
- 12.3.11.1 Company Overview
- 12.3.11.2 Product Portfolio
12.3.12 ResMed
- 12.3.12.1 Company Overview
- 12.3.12.2 Product Portfolio
- 12.3.12.3 Financials
- 12.3.12.4 SWOT Analysis
12.3.13 Somnomed Ltd
- 12.3.13.1 Company Overview
- 12.3.13.2 Product Portfolio
- 12.3.13.3 Financials
12.3.14 Vyaire Medical Inc
- 12.3.14.1 Company Overview
- 12.3.14.2 Product Portfolio
12.3.15 Whole You Inc
- 12.3.15.1 Company Overview
- 12.3.15.2 Product Portfolio